Renosome Bio, Inc.

Biotechnology company · Manchester, Connecticut, United States

Renosome Bio, Inc. is a biotechnology company headquartered in Manchester, Connecticut, United States. Its earliest recorded incorporation is in 2024. It has reported private securities offerings to the US SEC, most recently $150,000 sold in a notice filed in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

Renosome Bio at a glance

Typebiotechnology company

HeadquartersManchester, Connecticut, United States

Earliest incorporation on record2024

SEC CIK2040026

What does Renosome Bio do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $150,000 sold (2024).

Frequently asked questions about Renosome Bio

Where is Renosome Bio headquartered?

Renosome Bio, Inc. is headquartered in Manchester, Connecticut, United States.

What does Renosome Bio do?

Renosome Bio, Inc. is a biotechnology company.

When was Renosome Bio founded?

The earliest incorporation on record for Renosome Bio, Inc. is in 2024, according to public company registers.

Similar companies

Diant Pharma Inc.Manchester, Connecticut, United States
Recursion PharmaceuticalsSalt Lake City, Utah, United States
Vericel CorpBurlington, Massachusetts, United States
SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Adaptive Biotechnologies CorpSeattle, Washington, United States
Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
Cognition Therapeutics IncPurchase, New York, United States
Agenus IncLexington, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences